Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment.

Saved in:
Bibliographic Details
Title: Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment.
Authors: Aquaro S; Department of Experimental Medicine and Biochemical Sciences, University of Rome, Tor Vergata, Rome, Italy. aquaro@uniroma2.it, D'Arrigo R, Svicher V, Perri GD, Caputo SL, Visco-Comandini U, Santoro M, Bertoli A, Mazzotta F, Bonora S, Tozzi V, Bellagamba R, Zaccarelli M, Narciso P, Antinori A, Perno CF
Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2006 Oct; Vol. 58 (4), pp. 714-22. Date of Electronic Publication: 2006 Aug 05.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0305-7453 (Print) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0305-7453
DOI:10.1093/jac/dkl306